ITMI911880A1 - Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph. - Google Patents

Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.

Info

Publication number
ITMI911880A1
ITMI911880A1 IT001880A ITMI911880A ITMI911880A1 IT MI911880 A1 ITMI911880 A1 IT MI911880A1 IT 001880 A IT001880 A IT 001880A IT MI911880 A ITMI911880 A IT MI911880A IT MI911880 A1 ITMI911880 A1 IT MI911880A1
Authority
IT
Italy
Prior art keywords
preparation
value
active substances
extended release
containing active
Prior art date
Application number
IT001880A
Other languages
English (en)
Inventor
Ubaldo Conte
Paolo Giunchedi
Original Assignee
Farcon Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farcon Ag filed Critical Farcon Ag
Priority to ITMI911880A priority Critical patent/IT1250654B/it
Publication of ITMI911880A0 publication Critical patent/ITMI911880A0/it
Priority to AU22293/92A priority patent/AU2229392A/en
Priority to PCT/EP1992/001503 priority patent/WO1993000889A1/en
Priority to CN92111078.2A priority patent/CN1082888A/zh
Publication of ITMI911880A1 publication Critical patent/ITMI911880A1/it
Application granted granted Critical
Publication of IT1250654B publication Critical patent/IT1250654B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
ITMI911880A 1991-07-08 1991-07-08 Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph. IT1250654B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITMI911880A IT1250654B (it) 1991-07-08 1991-07-08 Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
AU22293/92A AU2229392A (en) 1991-07-08 1992-07-03 Method for the preparation of prolonged-release oral pharmaceutical forms containing active substances having a solubility dependent upon the ph value
PCT/EP1992/001503 WO1993000889A1 (en) 1991-07-08 1992-07-03 METHOD FOR THE PREPARATION OF PROLONGED-RELEASE ORAL PHARMACEUTICAL FORMS CONTAINING ACTIVE SUBSTANCES HAVING A SOLUBILITY DEPENDENT UPON THE pH VALUE
CN92111078.2A CN1082888A (zh) 1991-07-08 1992-08-24 用于制备包含其溶解性依赖于pH值的活性物质的缓释口服药物剂型的方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI911880A IT1250654B (it) 1991-07-08 1991-07-08 Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
CN92111078.2A CN1082888A (zh) 1991-07-08 1992-08-24 用于制备包含其溶解性依赖于pH值的活性物质的缓释口服药物剂型的方法

Publications (3)

Publication Number Publication Date
ITMI911880A0 ITMI911880A0 (it) 1991-07-08
ITMI911880A1 true ITMI911880A1 (it) 1993-01-08
IT1250654B IT1250654B (it) 1995-04-21

Family

ID=36790863

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911880A IT1250654B (it) 1991-07-08 1991-07-08 Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.

Country Status (4)

Country Link
CN (1) CN1082888A (it)
AU (1) AU2229392A (it)
IT (1) IT1250654B (it)
WO (1) WO1993000889A1 (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
WO1999047073A1 (en) * 1998-03-19 1999-09-23 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
EP1027885B1 (en) * 1999-02-09 2008-07-09 Pfizer Products Inc. Basic drug compositions with enhanced bioavailability
DE60039379D1 (de) * 1999-02-10 2008-08-21 Pfizer Prod Inc Pharmazeutische feste Dispersionen
ATE404178T1 (de) * 1999-02-10 2008-08-15 Pfizer Prod Inc Vorrichtung mit matrixgesteuerter wirkstofffreisetzung
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
PT1183014E (pt) 1999-06-14 2003-12-31 Cosmo Spa Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor
KR100540035B1 (ko) * 2002-02-01 2005-12-29 주식회사 태평양 다단계 경구 약물 방출 제어 시스템
EP1591107A1 (en) * 2004-04-28 2005-11-02 Pfizer GmbH Arzneimittelwerk Gödecke Process for the selective increase of a release rate of an active material from a pharmaceutical composition
US20070092559A1 (en) * 2005-10-24 2007-04-26 Jinghua Yuan Liquid dosage forms having enteric properties of delayed and then sustained release
ES2348157T3 (es) * 2006-12-15 2010-11-30 Campina Nederland Holding B.V. Excipiente de liberación modificada y su uso.
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
KR102505099B1 (ko) * 2019-03-28 2023-03-03 농업회사법인 보길바이오 주식회사 생체고분자 분자구조의 꼬임 및 풀림을 이용한 미세물질 포집 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1467781A1 (de) * 1963-07-15 1968-12-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
JPS6248618A (ja) * 1985-08-27 1987-03-03 Zeria Shinyaku Kogyo Kk 徐放性製剤およびその製造法
DE3769707D1 (de) * 1986-06-17 1991-06-06 Recordati Chem Pharm Therapeutisches system mit geregelter wirkstoffabgabe.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
ZA881301B (en) * 1987-02-27 1989-10-25 Lilly Co Eli Sustained release matrix formulations

Also Published As

Publication number Publication date
IT1250654B (it) 1995-04-21
CN1082888A (zh) 1994-03-02
WO1993000889A1 (en) 1993-01-21
ITMI911880A0 (it) 1991-07-08
AU2229392A (en) 1993-02-11

Similar Documents

Publication Publication Date Title
MA22894A1 (fr) Procede de preparation d'un vaccin.
ITBO910024A1 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
MA22626A1 (fr) Procede de preparation d'acides imidazolyl-alcenoiques .
ITBO910113A1 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
ITRM910696A0 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
FR2681959B1 (fr) Systeme d'impression.
DE69224656T2 (de) Arzneimittel
DE68900994D1 (de) Diphosphonsaeurederivat enthaltendes arzneimittel zur oralen gabe.
DE69203242D1 (de) Arzneimittel bestehend aus diltiazem in retardformen.
HU9203180D0 (en) Method for producing 2-desoxi-2,3-didehydro-n-acetyl-neuraminic acid derivatives and anti-viral pharmaceutical preparatives containing these compounds
AU6314790A (en) Oral pharmaceutical composition for acid sensitive proteinaceous agents
ITMI911880A1 (it) Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
NZ231353A (en) Pharmaceutical compositions comprising 3,5-dihydroxy-7-(1-acyloxyhexahydronaphth-8-yl)-heptanoic acid and lactone derivatives
NL194966B (nl) 3(2H)-Pyridazinonderivaten en werkwijze voor de bereiding ervan; farmaceutische samenstelling.
IT8919074A0 (it) Composizione per l'igiene orale.
IT9047924A0 (it) Composizione per l'igiene orale.
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
DE58905106D1 (de) Neue 1,2-dithiol-3-thion-s-oxid-verbindungen enthaltende arzneimittel.
OA09301A (fr) "Nouvelle forme galénique orale améliorant la biodisponibilité".
FR2702960B1 (fr) Leurre pour l'administration orale de médicaments vétérinaires.
ITPN920071A0 (it) Sistema di bloccaggio dell'orientamento a 360° del moncone preangolato per implantologia orale.
ZA908298B (en) Optically active thiazetoquinoline-3-carboxylic acid compound,method for preparation thereof,and a pharmaceutical composition comprising the same
ITPD920043A0 (it) Composto per la corretta rilevazione di impronte dentali
DE3887237D1 (de) Arzneimittel.
EE9400082A (et) 3- asendatud 1, 2, 3, 4- oksatriasool- 5- imiinühendid, nende saamise meetod ja nimetatud ühendeid sisaldav farmatseutiline preparaat

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950728